Literature DB >> 11600527

Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.

J Koranyi1, J Svensson, G Götherström, K S Sunnerhagen, B Bengtsson, G Johannsson.   

Abstract

The consequences of GH deficiency may differ if the disease is childhood onset or adulthood onset. In this single-center, prospective study, 21 consecutive adults with childhood onset GH deficiency and 21 adults with adulthood onset GH deficiency, matched for age, gender, body mass index, and number of anterior pituitary hormonal deficiencies, were included. Baseline differences and differences in the responses in body composition, muscle strength, bone mass, and metabolic indices during 5-yr GH replacement were determined. The duration of GH deficiency was longer and serum IGF-I level and body height were lower in the childhood onset patients than in the adulthood onset patients. Body fat (observed/predicted ratio) was increased, and lean mass and muscle strength were decreased, in the childhood onset patients. Total body and lumbar (L2-L4) bone mineral content and bone mineral density were lower in the childhood onset patients. Serum total cholesterol level was higher in the adulthood onset patients. The childhood onset and adulthood onset patients received a similar dose of GH. After adjustment for body weight, however, the dose of GH was higher in the childhood onset patients. The treatment responses were more marked in the childhood onset patients in lean mass, knee extensor strength, left-hand grip strength, and in total body and lumbar (L2-L4) bone mineral content and bone mineral density. The reduction in serum total cholesterol concentration was more marked in the adulthood onset patients. At study end, no differences remained between the two study groups after the correction for body height in the statistical analysis. In conclusion, the baseline analysis suggests more decreased lean mass, muscle strength, and bone mass in the childhood onset patients whereas the lipid profile was more disturbed in the adulthood onset patients. The 5-yr GH replacement eliminated all the anthropodometric and metabolic differences between the two groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11600527     DOI: 10.1210/jcem.86.10.7896

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Two years of growth hormone replacement therapy in a group of patients with Sheehan's syndrome.

Authors:  Débora Vieira Soares; Luciana Diniz Carneiro Spina; Rosane Resende de Lima Oliveira Brasil; Priscila Marise Lobo; Elizabeth Salles; Claúdia Medina Coeli; Flávia Lúcia Conceição; Mario Vaisman
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA.

Authors:  G Aimaretti; R Attanasio; S Cannavò; M C Nicoletti; R Castello; C Di Somma; P Garofalo; L Iughetti; S Loche; M Maghnie; L Mazzanti; G Saggese; M Salerno; G Tonini; V Toscano; S Zucchini; M Cappa
Journal:  J Endocrinol Invest       Date:  2014-11-02       Impact factor: 4.256

4.  Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Susan L Greenspan; Donna King; Amir Hamrahian; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  J Clin Endocrinol Metab       Date:  2011-03-02       Impact factor: 5.958

5.  A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis.

Authors:  Nicholas A Tritos; Amir H Hamrahian; Donna King; Susan L Greenspan; David M Cook; Peter J Jönsson; Michael P Wajnrajch; Maria Koltowska-Häggstrom; Beverly M K Biller
Journal:  Eur J Endocrinol       Date:  2012-06-18       Impact factor: 6.664

Review 6.  Growth hormone release during acute and chronic aerobic and resistance exercise: recent findings.

Authors:  Laurie Wideman; Judy Y Weltman; Mark L Hartman; Johannes D Veldhuis; Arthur Weltman
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

7.  Consequences of lifetime isolated growth hormone (GH) deficiency and effects of short-term GH treatment on bone in adults with a mutation in the GHRH-receptor gene.

Authors:  Francisco J A de Paula; Miburge B Góis-Júnior; Manuel H Aguiar-Oliveira; Francisco de A Pereira; Carla R P Oliveira; Rossana M C Pereira; Catarine T Farias; Tábita A R Vicente; Roberto Salvatori
Journal:  Clin Endocrinol (Oxf)       Date:  2008-05-20       Impact factor: 3.478

8.  Provincial disparities of growth hormone coverage for young adult survivors of paediatric brain tumours across Canada.

Authors:  Haroon Hasan; Fuchsia Howard; Steven G Morgan; Daniel L Metzger; Andrea C Lo; Karen Goddard; Sabrina Gill; Michelle Johnson
Journal:  Healthc Policy       Date:  2014-02

9.  Could zinc supplementation improve bone status in growth hormone (GH) deficient children?

Authors:  Flavia Prodam; Gianluca Aimaretti
Journal:  Endocrine       Date:  2013-01-30       Impact factor: 3.633

Review 10.  Individual sensitivity to growth hormone replacement in adults.

Authors:  Cesar Luiz Boguszewski
Journal:  Rev Endocr Metab Disord       Date:  2020-10-07       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.